Professional Supplier of Nano-Targeted Drug Scientific Research Products

Liposomes

PG-based Fluoroliposome-DiD-DBCO, Lyophilized Powder

Catalog: TASK-25-6000498   CAS NO.: N/A
Delivery Fill in your shipping address to check the estimated shipping fee of your order

Select Shipping Address

$0.00 delivery Normal Delivery(7Days) Details Cyprum itidem insulam procul a continenti

$0.00 delivery Express Delivery Details Cyprum itidem insulam procul a continenti

  • High Quality Products
  • Fast and Safe Delivery

Description

PG-based Fluoroliposome-DiD-DBCO, Lyophilized Powder enables specific drug delivery to particular tissues or cell types. This has key advantages in both cancer therapy and other targeted treatments. This liposome can be modified with tumor-targeting ligands (such as antibodies or peptides) that bind to overexpressed tumor-specific antigens (e.g., HER2, EGFR). This allows the liposome to selectively deliver chemotherapy drugs or small molecules to tumor cells, enhancing therapeutic efficacy while minimizing off-target toxicity. PG-based Fluoroliposome-DiD-DBCO can also be engineered to deliver antiviral drugs or vaccines to infected cells. Conjugation with viral receptor-targeting molecules can ensure that the liposome delivers its payload specifically to infected cells, minimizing systemic toxicity and improving the therapeutic outcome.

Specifications

CAS No.N/A
Lipid Composition1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)/1,2-dioleoyl-sn-glycero-3-phosphocholine/Cholesterol/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-dibenzocyclooctyl (20/49/30/1)
FormLyophilized Powder
Ship Within1 week
Storage Temp.-20℃
Shipping4-25℃ for up to 3 weeks
Welcome to Taskcm

This email already exists.

Username already exists.

Please confirm the password is the same.

or